Biotech's Freer Hand to Fight Terror
With the severe acute respiratory syndrome (SARS) epidemic spreading, it's easy to overlook an equally serious threat: bioterrorism. The situation in Iraq and heightened tension throughout the Middle East may raise the likelihood of a chemical or biological attack against U.S. targets. The Homeland Security Dept. has repeatedly warned that terrorist groups could be planning such assaults (see BW Online, 4/28/03, "'Security Becomes Embedded'"). And as the still-unsolved anthrax attacks of 2001 showed, America's arsenal of vaccines and drugs is far from adequate.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Billionaire Tom Barrack Throws Harvey Weinstein a Lifeline
- Everything Is Crazy and the Markets Aren’t Freaking Out
- Facebook Is Looking for Employees With National Security Clearances
- Gulf of Mexico Oil Spill May Be Largest Since BP Disaster
- Kushners’ Control of Family’s NYC Crown Jewel Is Now in Jeopardy